Differences in risk for SARS-CoV-2 infection among healthcare workers
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2021.03.30.21254653: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Participants signed a written informed consent that included permission to link to the hospital administrative databases for information on professional role (physician, nurse/midwife, nurse assistant, or other), sick leave records and hospital unit assignment (s). Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources SARS-CoV-2 IgG antibodies were analysed using three different virus protein variants, namely the trimeric full-length Spike protein (14) expressed in HEK cells, the Spike S1 domain expressed in … SciScore for 10.1101/2021.03.30.21254653: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Participants signed a written informed consent that included permission to link to the hospital administrative databases for information on professional role (physician, nurse/midwife, nurse assistant, or other), sick leave records and hospital unit assignment (s). Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources SARS-CoV-2 IgG antibodies were analysed using three different virus protein variants, namely the trimeric full-length Spike protein (14) expressed in HEK cells, the Spike S1 domain expressed in CHO cells and the Nucleocapsid protein expressed in E. coli. SARS-CoV-2 IgGsuggested: NoneCaptured IgG antibodies were detected by fluorescent anti-hIgG (Invitrogen, H10104) and reported as relative fluorescence intensity (AU). anti-hIgGsuggested: (Antibodies-Online Cat# ABIN288163, RRID:AB_10795674)Experimental Models: Cell Lines Sentences Resources SARS-CoV-2 IgG antibodies were analysed using three different virus protein variants, namely the trimeric full-length Spike protein (14) expressed in HEK cells, the Spike S1 domain expressed in CHO cells and the Nucleocapsid protein expressed in E. coli. HEKsuggested: CLS Cat# 300192/p777_HEK293, RRID:CVCL_0045)CHOsuggested: CLS Cat# 603479/p746_CHO, RRID:CVCL_0213)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: We found the following clinical trial numbers in your paper:
Identifier Status Title NCT04411576 Recruiting Current and Past SARS-CoV-2 Infection and COVID-19 in Health… Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
